PMA N50510S144

Device
VITEK GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR QUINUPRISTIN/DALFOPRISTIN
Applicant
Biomerieux Vitek, Inc.
PMA number
N50510
Supplement
S144
Product code
LTW
Decision date
2001-06-13
Classification
Susceptibility Test Cards, Antimicrobial
Generic name
Susceptibility test cards, antimicrobial
Approval order statement
APPROVAL FOR THE ADDITION OF THE ANTIBIOTIC QUINUPRISTIN/DALFOPRISTIN AT CONCENTRATIONS OF 0.75, 1.5, AND 3 MCG/ML TO THE VITEK. GRAM POSITIVE SUSCEPTIBILITY PANEL. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME VITEK. GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR QUINUPRISTIN/DALFOPRISTIN, AND IS INDICATED FOR USE IN VITEK. GRAM POSITIVE SUSCEPTIBILITY TEST CARDS FOR THE SUSCEPTIBILITY TESTING OF METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS, VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM, STAPHYLOCOCCUS EPIDERMIDIS, AND STREPTOCOCCUS AGALACTIAE ISOLATE TO QUINUPRISTIN/DALFOPRISTIN IN THE RANGE OF <=.5 TO >=4 MCG/ML.

Current openFDA PMA Record#

Device
VITEK GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR QUINUPRISTIN/DALFOPRISTIN
Applicant
Biomerieux Vitek, Inc.
PMA number
N50510
Supplement
S144
Product code
LTW
Generic name
Susceptibility test cards, antimicrobial
Decision date
2001-06-13
Decision code
APPR
Date received
2001-01-03
Supplement type
Normal 180 Day Track
Supplement reason
Other
Approval order statement
APPROVAL FOR THE ADDITION OF THE ANTIBIOTIC QUINUPRISTIN/DALFOPRISTIN AT CONCENTRATIONS OF 0.75, 1.5, AND 3 MCG/ML TO THE VITEK. GRAM POSITIVE SUSCEPTIBILITY PANEL. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME VITEK. GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR QUINUPRISTIN/DALFOPRISTIN, AND IS INDICATED FOR USE IN VITEK. GRAM POSITIVE SUSCEPTIBILITY TEST CARDS FOR THE SUSCEPTIBILITY TESTING OF METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS, VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM, STAPHYLOCOCCUS EPIDERMIDIS, AND STREPTOCOCCUS AGALACTIAE ISOLATE TO QUINUPRISTIN/DALFOPRISTIN IN THE RANGE OF =4 MCG/ML.